The Optimization of a Dimenhydrinate Transdermal Patch Formulation Based on the Quantitative Analysis of In Vitro Release Data by DDSolver through Skin Penetration Studies
Dimenhydrinate is an over-the-counter medication that is used to relieve nausea, vomiting, and vertigo caused by motion sickness. It has a short elimination half-life, possibly due to its first-pass metabolism. The current study aimed to prepare and evaluate new transdermal formulations of dimenhydr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Österreichische Apotheker-Verlagsgesellschaft m. b. H.
2021-07-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-0532/89/3/33 |